RT Journal Article
SR Electronic
T1 671 Phase 1 trial of human chimeric antigen receptor modified T cells (huCART-meso) administered in combination with oncolytic virus VCN-01 in patients with pancreatic and ovarian cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A760
OP A761
DO 10.1136/jitc-2023-SITC2023.0671
VO 11
IS Suppl 1
A1 Tanyi, Janos L
A1 O’Hara, Mark H
A1 Hexner, Elizabeth
A1 Marshall, Amy
A1 Jadlowsky, Julie
A1 Ferrara, Matthew
A1 Farrelly, Olivia
A1 Runkle, Adam
A1 Chew, Anne
A1 Dowd, Emily
A1 Gonzalez, Vanessa
A1 Fraietta, Joseph A
A1 Plesa, Gabriela
A1 Sheppard, Neil C
A1 June, Carl H
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A760.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.